Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm PortAI, I can summarize articles.
Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 2.17% to $8.10 on Tuesday, underperforming against competitors amid a declining stock market. The NASDAQ Composite Index dropped 1.43%, while the Dow Jones Industrial Average fell 0.34%. Corbus is currently 60.60% below its 52-week high of $20.56. In contrast, Vanda Pharmaceuticals Inc. rose 4.01%, while Fortress Biotech Inc. and Viking Therapeutics Inc. saw minor declines. Trading volume was significantly below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments